UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Bio and Pharmaceutical Stocks Smiling in the First Week of 2017
Some bio and pharmaceutical companies whose stock prices drop range were la...
by Nam Doo-hyun
|
2017-01-17 09:09
라인
Green Cross LabCell Got the Patent to Make Mass Production of a Cell Therapy Product
Green Cross LabCell got the patent to make mass production of the cell therapy product.The company (CEO Bok-soo Park) an...
by Constance Williams
|
2017-01-16 11:17
라인
Takeda Pharmaceuticals Korea, Labor-Management Conflict
The Takeda Pharmaceuticals Korea Co., Ltd is in trouble because of conflict...
by Park Gi-taek
|
2017-01-13 16:15
라인
Green Cross Wins a Massive Amount of the Contract to Provide Varicella Vaccine to PAHO
Green Cross plans to export massive amounts of varicella vaccine and became...
by Lee Hye-seon
|
2017-01-12 16:49
라인
Last Year, Export and Import of Pharmaceutical Products Exceeded $2billion and $5billion for the First Time
Last year, the amount of money for export and import of pharmaceutical prod...
by Nam Doo-hyun
|
2017-01-06 15:15
라인
44% Officials at pharmaceutical companies say “The election of Trump is a crisis”
Officials at pharmaceutical companies think the election of Donald J Trump ...
by Lee Hye-seon
|
2016-12-20 10:36
라인
"Controversial Layoff of Poor-Performing Workers? Bayer Korea Is Even Worse"
As labor opposes the "poor-performance layoffs," which allow companies to f...
by Nam Doo-hyun
|
2016-12-18 17:47
라인
Why did Janssen Postpone Critical Tests for a New Medicine for Diabetic Released by Hanmi Pharmaceutical?
Hanmi Pharmaceutical Co., Ltd has been under controversy because the contra...
by Lee Hye-seon
|
2016-12-13 07:20
라인
Angry Sanofi Labor Union's Upcoming Strikes
“Does 1% salary increase ratio make sense for the top company in terms of o...
by Park Gi-taek
|
2016-12-08 08:32
라인
Daehwa Pharmaceutical Signs $20 Million Export Contract in Middle East and Africa
Daehwa Pharmaceutical will export drugs to eleven countries in the Middle East and North Africa.On October 12, Daehwa Ph...
by Lee Hye-seon
|
2016-11-08 10:28
라인
The Fall of GSK, Once the No.1 in Sales and Workforce
GlaxoSmithKline(GSK), once the number one in sales among the multinational ...
by Lee Jung-su
|
2016-10-31 14:40
라인
Last Year's Report Card of Multinational Pharmaceutical Companies in South Korea
Last year, multinational pharmaceutical companies recorded astonishing sales.According to the 2015 audit reports of majo...
by Lee Jung-su
|
2016-10-07 14:06
라인
Corporate Restructuring at GSK: Raising Wages of Executives While Reducing Staff
GlaxoSmithKline(GSK), which tightened its belt after laying off 176 employe...
by Nam Doo-hyun
|
2016-10-03 08:25
라인
Daewoong Pharmaceutical, Sulbacillin Permit Revoked
The product license of the Sulbacillin injection, an antibiotic by Daewoong Pharmaceutical Company has been revoked. The...
by Lee Hye-seon
|
2016-10-02 09:33
라인
Green Cross Aims to Become World's Fifth in the Production of Blood Products
Green Cross increased the domestic production facility for blood products, aiming to become the world's fifth in the...
by Lee Hye-seon
|
2016-10-02 09:28
라인
A Product Manager Answering Her Own Questions: Handok’s Clearteen Ad Deceived Consumers
A Handok employee allegedly wrote posts on web portals disguised as a consu...
by Nam Doo-hyun
|
2016-10-02 09:18
라인
Can a New Korean Drug, Kanarb Become a Global Hit?
The possibility of Korea's new drug no. 15, Kanarb (active ingredient: ...
by Lee Hye-seon
|
2016-10-02 08:30
-
이전
121
122
123
124
125
126
127
128
129
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top